| Bristol-Myers Squibb SA - Baraclude 0.05 mg/mL, Lösung zum Einnehmen | | 57436 | | 01 | | Baraclude 0.05 mg/mL | | Lösung zum Einnehmen | | J05AF10 | | Entecavir | | 10.08.2006 | | |
| | Composition | | entecavirum 0.05 mg, maltitolum 380 mg, acidum citricum, natrii citras dihydricus, natrii hydroxidum, acidum hydrochloridum, aqua purificata, aromatica cum ethanolum q.s., propylis parahydroxybenzoas 180 µg, E 218 1.5 mg, ad solutionem pro 1 ml corresp. natrium 0.3 mg. | | Packungsbestandteile | | Solution (orale) | | | | | | Principe actif | Concentr. |
|---|
| Entecavir | 0.05 mg/ml |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Acide Citrique | | | | Acidum Hydrochloridum | | | | Aqua Purificata | | | | Aromatica cum Ethanolum q.S. | | | | E 218 | 1.5 mg/ml | conserv. | | Maltitol | 380 mg/ml | | | Natrii Citras Dihydricus | | | | Sodium Hydroxide | | | | Propylis Parahydroxybenzoas | 180 µg/ml | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 210 ml | DDP | DDP | A | | Oui |
|
|
